SARAH DJALI PURVIS: Open Payments
NPI 1225532666 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,199 in 72 payments from 18 companies in 2025. Trend: 2023 $2,529 · 2024 $2,804 · 2025 $3,199
Food & beverage: $1,974Consulting: $1,125Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 11 | $1,531 |
| ABBVIE INC. | 9 | $378 |
| GENZYME CORPORATION | 4 | $163 |
| Regeneron Healthcare Solutions, Inc. | 4 | $135 |
| Novartis Pharmaceuticals Corporation | 5 | $123 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $123 |
| Amgen Inc. | 4 | $120 |
| Incyte Corporation | 4 | $98 |
| Galderma Laboratories, L.P. | 4 | $94 |
| PFIZER INC. | 4 | $83 |
Products named: TREMFYA, DUPIXENT, RINVOQ, SKYRIZI, ILUMYA, OTEZLA, OPZELURA, COSENTYX.
Industry payments across NC — which companies pay providers there.
